![Research / Clinical research / Pharmaceutical industry / Food and Drug Administration / Cyclopropanes / Tasimelteon / Non-24-hour sleep-wake disorder / New Drug Application / Pharmaceutical sciences / Health / Pharmacology Research / Clinical research / Pharmaceutical industry / Food and Drug Administration / Cyclopropanes / Tasimelteon / Non-24-hour sleep-wake disorder / New Drug Application / Pharmaceutical sciences / Health / Pharmacology](https://www.pdfsearch.io/img/f4e4da6740b1b0b633567a368ad2fec6.jpg) Research Clinical research Pharmaceutical industry Food and Drug Administration Cyclopropanes Tasimelteon Non-24-hour sleep-wake disorder New Drug Application Pharmaceutical sciences Health Pharmacology | | FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) Meeting Sheraton Silver Spring Hotel, Cypress Ballroom 8777 Georgia Add to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 24,78 KBShare Document on Facebook
|